Biogen and Sage Present Positive Data for Breakthrough Depression Therapy

Sage Therapeutics and Biogen today announced positive and consistent results from their ongoing clinical trials on the efficacy and safety of zuranolone in treating major depressive disorder (MDD) and postpartum depression (PPD).